NB-MED - 2.1 - Rec - 1-2010 Representative Sample

Download as pdf or txt
Download as pdf or txt
You are on page 1of 3

Co-ordination of

Notified Bodies Medical Devices


Recommendation
(NB-MED)
on Council Directives 90/385/EEC, NB-MED/2.1/Rec1
93/42/EEC and 98/79/EC

Title: Representative Sample

Chapter: 2.1 Scope, field of application, explanation of terms

Text: ---
Key words: sample

A "representative sample" of production for EC type examination is any one product


manufactured according to the documentation delivered.

A rationale and history sheet is available; please contact Technical Secretariat.

Reference to Article/ Reference to standards:


Directives: Annex:
AIMD Annex: 3-1
MDD Annex: III-1
IVDD Annex: V-1, VI-1, VI-4 prENxxx “Sampling procedures
used for acceptance testing of
in vitro diagnostic medical
devices”

Stage proposed by Rev.-Nr. Rev. date accepted amended withdrawn Page


3 4 03.02.2000 06.06.2000 1/1

VdTÜV G. Hinrich Schaub (- 178) Phone: ++49/201/8987- 0


Technical Secretariat NB-MED Jörg Höppner (- 138) Fax: ++49/201/8987- 120
PO Box 10 38 34 Kurfürstenstraße 56 eMail: [email protected]
D-45038 Essen D-45138 Essen
vdtuev-file: ...\hoeppner\mp\nb\rec_vdt2\R2_1-1_rev4.doc
Rationale and
Co-ordination of
Notified Bodies Medical Devices
history sheet
(NB-MED) to
on Council Directives 90/385/EEC, NB-MED/2.1/Rec1
93/42/EEC and 98/79/EC

Title: Representative Sample

Rev. 2: Notified Body Meeting, Brussels, September. 24 & 25. 1996:


The document was approved by the NB-MED plenary.
Confirmed at stage 3.
New revision no: 2

Rev. 3: Meeting of NBR Group, Brussels, November 7, 1996:


The NBRG has brought the document into the format of a NB-MED recommen-
dation and issued it among their „stage 3“-recommendations. Some minor
changes were done.
Confirmed at stage 3.
New revision no: 3

Medical Devices Expert Group Meeting, Brussels, February 9 & 10, 1998:
The stage 3 document was presented to the Medical Devices Experts Group and
accepted without changes:
Confirmed at stage 4.

Rev. 4: Notified Body Meeting, Brussels, November, 2 & 3, 1999:


The NBRG was asked to rework the NB-MED Recommendations in light of the
IVD-directive.

Meeting of NBR Group, Cologne, February 3, 2000:


The work results of a small task force (task: reworking the Recommendations)
were presented to that NBRG-meeting.
The tabled revised Recommendation was discussed and NBRG agreed that the
document, as discussed and revised, should be presented for adoption at the
February/March NB-MED Plenary meeting. Only some editorial changes were
made.
Revision no: 4
stage 2

Notified Body Meeting, Brussels, February 29, & March 1, 2000:


Dr. Holland reported that the current and valid/accepted stage 4 document (see
NBM/123/99) was in the meanwhile revised by the NBRG/IVD task force (see
NBM/35/00). Changes were made in light of the IVDD. Some comments have
arrived and there is a need for incorporation those. The NB-MED agreed that
further development on this Recommendation will be made within NBRG. A
revised draft document should be presented at the next plenary (IVDD) meeting
in June. Up to there the already accepted stage 3 document will be kept still
valid.
Revision no: 4
stage 2

Rev.-Nr. Rev. date accepted amended withdrawn Page


06.06.2000 1/2

VdTÜV G. Hinrich Schaub (- 178) Phone: ++49/201/8987- 0


Technical Secretariat NB-MED Jörg Höppner (- 138) Fax: ++49/201/8987- 120
PO Box 10 38 34 Kurfürstenstraße 56 eMail: [email protected]
D-45038 Essen D-45138 Essen
vdtuev-file: ...\hoeppner\mp\nb\rec_vdt2\R2_1-1_rev4.doc
Rationale and
Co-ordination of
Notified Bodies Medical Devices
history sheet
(NB-MED) to
on Council Directives 90/385/EEC, NB-MED/2.1/Rec1
93/42/EEC and 98/79/EC

Meeting of NBR Group, Brussels, April 10 &11, 2000:


The document was once again accepted by NBRG in the same form as already
presented to the last plenary meeting in March. NBRG agreed that the
document, should be presented for adoption at the June NB-MED Plenary
meeting.
Revision no: 4
stage 2

Notified Body Meeting, Brussels, June 6 & 7, 2000:


The document (NBM/56/00) was approved by the NB-MED plenary.
Confirmed at stage 3.
Revision no: 4

Page
2/2

vdtuev-document dn: ...\hoeppner\mp\nb\rec_vdt2\R2_1-1_rev4.doc

You might also like